As of Friday close, Syneos Health Inc.’s (NASDAQ:SYNH) stock was down -$0.03, moving down -0.07 percent to $42.74. The average number of shares traded per day over the past five days has been 1,341,640 shares. 3 times new highs have been achieved over the past 5 days. In the last twenty days, the average volume was 1,171,820, while in the previous 50 days, it was 1,206,374.
Since last month, SYNH stock rose 0.61%. Shares of the company fell to $42.45 on 08/25/23, the lowest level in the past month. A 52-week high of $52.23 was reached on 09/13/23 after having rallying from a 52-week low of $22.89. Since the beginning of this year, SYNH’s stock price has risen by 16.52% or $6.06, and marked a new high 7 times. However, the stock has declined by -18.17% since its 52-week high.
Top 5 AI Stocks to Buy for 2023
The artificial intelligence (AI) revolution is already here. And it's about to change everything we know about everything.
According to Grand View Research, the global AI boom could grow from about $137 billion in 2022 to more than $1.81 trillion by 2030. And investors like you always want to get in on the hottest stocks of tomorrow. Here are five of the best ways to profit from the AI boom.
Click Here to Download the FREE Report.
Sponsored
Valuation Metrics
Right now, Syneos Health Inc. (SYNH) has a P/E ratio of about 61.85. The stock’s beta is 1.56. Besides these, the trailing price-to-sales (P/S) ratio of 0.82, the price-to-book (PB) ratio of 1.27, and the price-to-cash flow ratio of 27.40 may also be considered.
Financial Health
In the three months ended June 29, Syneos Health Inc.’s quick ratio stood at 1.20, while its current ratio was 1.20, showing that the company is able to pay off its debt. According to company report, the long-term debt-to-equity ratio for the quarter ending June 29 was 0.77, and the total debt-to-equity ratio was 0.77. On the profitability front, the trailing twelve-month gross margin is 22.10% percent. In the year ended June 29, EBITDA margin amounted to 13.10%, whereas operating margins totaled 4.00%. Based on annual data, SYNH earned $1.25 billion in gross profit and brought in $5.39 billion in revenue.
A company’s management is another factor that investors consider when determining the profitability of an investment. In the past year, return on investment (ROI) was 5.70%. Return on equity (ROE) for the past 12 months was 2.10%.
In Syneos Health Inc.’s quarter-end financial report for June 29, it reported total debt of $2.64 billion. According to the earnings report, the company had a higher net income in the recent quarter than it did in the previous quarter. SYNH’s revenue rose 0.39% to $1.36 billion during the quarter, while net income inched up to $1.37 billion. While analysts expected Syneos Health Inc. to report $0.79 quarterly earnings, the actual figure was $0.57 per share, beating the consensus estimate by -27.80%. During the quarter, the company generated $101.55 million in EBITDA. The liabilities of Syneos Health Inc. were 4.58 billion at the end of its most recent quarter ended June 29, and its total debt was $2.9 billion. The value of shareholders’ equity is $103.72 million.
Technical Picture
This quick technical analysis looks at Syneos Health Inc.’s (SYNH) price momentum. With a historical volatility rate of 1.10%, the RSI 9-day stood at 52.52% on 22 September.
At present, SYNH shares trade +0.61% above its 20-day simple moving average and +8.53% percent above its 100-day simple moving average. However, the stock is currently trading approximately +0.97% above its SMA50 and +23.31% above its SMA200.
Stochastic coefficient K was 14.05% and Stochastic coefficient D was 16.92%, while ATR was 0.12. Given the Stochastic reading of 11.76% for the 14-day period, the RSI (14) reading has been calculated as 57.31%.
Analyst Ratings
Syneos Health Inc. downgraded its rating on Syneos Health Inc. (NASDAQ: SYNH) to an Underweight in a note to investors on February 13, 2023. The analysts firm previously had a Neutral rating on the stock.Syneos Health Inc. (SYNH) has been rated Hold by analysts. According to 0 brokerage firms, SYNH is a sell, and 6 firms recommend it is a Hold. There are 0 analysts who say the stock is underweight. A total of 0 analysts rate Syneos Health Inc. stock as buy, with 0 recommending it as overweight.
With a median target price of $43.00, the current consensus forecast for the stock is $43.00 – $43.00. Based on these forecasts, analysts predict Syneos Health Inc. (SYNH) will achieve an average price target of $43.00.
